Carlisle Companies Incorporated (CSL)

Debt-to-equity ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 2,463,300 2,829,000 3,024,400 2,629,500 2,537,700
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $2,463,300K
= 0.00

The debt-to-equity ratio of Carlisle Companies Incorporated has been consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company's level of debt relative to its equity is minimal or non-existent during this period. A low or zero debt-to-equity ratio is generally viewed positively as it suggests that the company may have a strong financial position with low financial risk, as it is not heavily reliant on debt financing. However, it's important to note that a zero debt-to-equity ratio may also imply that the company is not utilizing leverage to potentially maximize returns for shareholders.


Peer comparison

Dec 31, 2024

Company name
Symbol
Debt-to-equity ratio
Carlisle Companies Incorporated
CSL
0.00
West Pharmaceutical Services Inc
WST
0.00